易方达标普生物科技人民币C(012866)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | ORIC | Oric Pharmaceuticals Inc | 21.19 | 0.07% |
| 2024-12-31 | CELC | Celcuity LLC | 20.56 | 0.07% |
| 2024-12-31 | ATXS | Astria Therapeutics Inc | 17.16 | 0.06% |
| 2024-12-31 | AKBA | Akebia Therapeutics Inc | 17.37 | 0.06% |
| 2024-12-31 | SGMO | Sangamo Therapeutics Inc | 18.22 | 0.06% |
| 2024-12-31 | YMAB | Y-mAbs Therapeutics Inc | 16.43 | 0.05% |
| 2024-12-31 | SCLX | Scilex Holding Co | 9.63 | 0.03% |
| 2024-12-31 | GLUE | Monte Rosa Therapeutics Inc | 9.78 | 0.03% |
| 2024-09-30 | UTHR | 联合治疗 | 804.56 | 2.53% |
| 2024-09-30 | INCY | 因塞特医疗 | 791.68 | 2.49% |
| 2024-09-30 | EXAS | 精密科学 | 791.25 | 2.49% |
| 2024-09-30 | ALNY | Alnylam Pharmaceuticals Inc | 789.4 | 2.49% |
| 2024-09-30 | ABBV | 艾伯维 | 774.11 | 2.44% |
| 2024-09-30 | GILD | 吉利德科学 | 770.74 | 2.43% |
| 2024-09-30 | NTRA | Natera Inc | 763.89 | 2.41% |
| 2024-09-30 | SRPT | Sarepta Therapeutics Inc | 762.78 | 2.4% |
| 2024-09-30 | BIIB | 生化基因 | 754.27 | 2.38% |
| 2024-09-30 | MRNA | Moderna Inc | 745.07 | 2.35% |
| 2024-06-30 | SRPT | Sarepta Therapeutics Inc | 986.52 | 3.11% |
| 2024-06-30 | UTHR | 联合治疗 | 887.21 | 2.8% |
公告&资料
